Abstract
Ashby has recently described a clear diagrammatic model for the presentation and assessment of test data from dominant lethal tests. From a regulatory perspective, this approach has the merit of providing data in a standard format. Having recently evaluated the dominant lethal test data for butadiene, we have identified several areas for consideration and discussion.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
